Comb_Synp_Brand_Name_Equal_posting_75N91019Q00125-A.pdf

TITLE:

Procurement of a Brand Name BD Biosciences upgrade to the National Cancer Institute (NCI), owned BD Fortessa Flow Cytometer equipment, Serial Number H5B300008

GENERAL INFORMATION

Document Type: Combined Synopsis/Solicitation Notice

Solicitation Number: 75N91019Q00125-A

Proposed Posted Date: September 7, 2019

Proposed Response Date: September 9, 2019

Classification Code: 65 – Medical, dental & veterinary equipment & supplies

NAICS Code: 334516 – Surgical and Medical Instrument Manufacturing

Business Size Standard: 1,000 Employees

CONTRACTING OFFICE ADDRESS

Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E126, Bethesda, MD 20892, UNITED

STATES.

Non-USPS mail such as FedEx, UPS and other private carriers please use Rockville, MD 20850.

This is a combined synopsis/solicitation for commercial items, prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation:

No. 75N91019Q00125-A includes all applicable provisions and clauses in effect through FAR FAC 2019-05 (August 2019) simplified procedures for commercial items.

The North American Industry Classification System code is 334516 and the business size standard is 1,000 employees.

It has been determined there are no opportunities to acquire green products or services for this procurement.

Only one award will be made as a result of this solicitation. This will be awarded as a Severable Firm Fixed Price type contract.

The services acquired under this contract are severable services. Funds are only available for use for the contract line item (CLIN) to which they are obligated. Unused funds from one CLIN may not rollover for use in other periods.

BACKGROUND

The National Cancer Institute (NCI), Pediatric Oncology Branch (POB) requires an upgrade for a Government Owned BD Biosciences Fortessa flow cytometer, Serial Number H5B300008. This will allow increased ability to detect cell surface markers on individual cells which will save reagents and time. The upgrade shall be compatible with the existing Government Owned BD

Biosciences Fortessa and current research protocols. The POB requires this Fortessa upgrade to support the ongoing clinical and basic research in the branch by providing cell phenotype data for both research and clinical samples from ongoing clinical trials. As newer markers are increasingly being incorporated to identify specific cell populations of interest from both basic and clinical samples, the POB will need a flow cytometer with the ability to detect more than eight (8) markers in a sample. By adding additional lasers and filter sets in the Fortessa upgrade, the NCI’s equipment will be able to detect 14 colors simultaneously; thus, allowing the NCI to use less samples (particularly important for clinical samples which are limited).

PRODUCT FEATURES/SALIENT CHARACTERISTICS

The upgrade shall provide the following product features/salient characteristics required for this requirement:

1. Must be compatible with existing BD Fortessa, Serial Number H5B300008 in the POB and allow for the ability to detect 14 fluorescent colors simultaneously.

2. Must provide 561 nm laser that will allow for the excitation of red and infrared fluorescent markers such as PE, PE-TxRed, PE-Cy5, PE-Cy5.5, PE-Cy7.

3. Must provide detectors and optics for the 628 nm laser that will allow for the excitation of red and infrared fluorescent dyes such as APC, AlexaFluor 700, and APC-Cy7.

4. Must have appropriate filter sets to allow for 14 color detection including red, green, blue, and ultraviolet excitable fluorescent markers.

5. Must have appropriate electronics and photomultiplier tubes to support the new lasers and filter sets.

6. All upgrade parts must be of proven design and reliability.

7. All shipping, delivery and installation costs must be included in the quote. NCI will not be responsible after award is made, if shipping costs are not included.

8. Coordination of delivery and installation with the NCI Technical Point of Contact (TPC).

DELIVERY / INSTALLATION

The Contractor shall deliver the item(s) within 90 days after award to:

National Cancer Institute 10 Center Drive Bethesda, MD 20892

PAYMENT

Payment shall be made once delivery and installation of equipment, and upon Government acceptance. Payment authorization requires submission and approval of invoice to the NCI TPC and NIH Commercial Accounts.

BASIS OF AWARD

The purchase order will be awarded to the Lowest Price Technically Acceptable (LPTA). The award will be made on the basis of the lowest evaluated price of quotations meeting or exceeding the acceptability standards for the requirements/technical specifications stated above. The technical evaluation will be a determination based on information furnished by the vendor. The Government is not responsible for locating or securing any information which is not identified in the quote. The Government reserves the right to make an award without discussions.

PROVISIONS AND CLAUSES

The following FAR provisions and clauses apply to this acquisition:

52.212-1 INSTRUCTIONS TO OFFERORS-COMMERCIAL ITEMS (OCT 2018);

52.212-2 EVALUATION COMMERCIAL ITEMS (OCTOBER 2014):

52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS-COMMERCIAL ITEMS

(OCT 2018) WITH DUNS NUMBER ADDENDUM {52.204-6 (OCT 2016)};

52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment.

REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO

SURVEILLANCE SERVICES OR EQUIPMENT (AUG 2019)

(a) Definitions. As used in this provision—

Covered telecommunications equipment or services, Critical technology, and Substantial or essential component have the meanings provided in clause 52.204-25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment.

(b) Prohibition. Section 889(a)(1)(A) of the John S. McCain National Defense Authorization Act for Fiscal Year 2019 (Pub. L. 115-232) prohibits the head of an executive agency on or after August 13, 2019, from procuring or obtaining, or extending or renewing a contract to procure or obtain, any equipment, system, or service that uses covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system.

Contractors are not prohibited from providing—

(1) A service that connects to the facilities of a third-party, such as backhaul, roaming, or interconnection arrangements; or

(2) Telecommunications equipment that cannot route or redirect user data traffic or permit visibility into any user data or packets that such equipment transmits or otherwise handles.

(c) Representation. The Offeror represents that—

It [ ] will, [ ] will not provide covered telecommunications equipment or services to the Government in the performance of any contract, subcontract or other contractual instrument resulting from this solicitation.

(d) Disclosures. If the Offeror has responded affirmatively to the representation in paragraph (c) of this provision, the Offeror shall provide the following information as part of the offer—

(1) All covered telecommunications equipment and services offered (include brand; model number, such as original equipment manufacturer (OEM) number, manufacturer part number, or wholesaler number; and item description, as applicable);

(2) Explanation of the proposed use of covered telecommunications equipment and services and any factors relevant to determining if such use would be permissible under the prohibition in paragraph (b) of this provision;

(3) For services, the entity providing the covered telecommunications services (include entity name, unique entity identifier, and Commercial and Government Entity (CAGE) code, if known);

and

(4) For equipment, the entity that produced the covered telecommunications equipment (include entity name, unique entity identifier, CAGE code, and whether the entity was the OEM or a distributor, if known).

(End of provision)

FAR Clause 52.212-4 CONTRACT TERMS AND CONDITIONS – COMMERCIAL ITEMS

(OCT 2018);

FAR Clause 52.212-5: CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS-COMMERCIAL ITEMS (AUG

2019). The following FAR clauses cited in paragraph (b) of the clause at FAR 52.212-5 are also applicable to this acquisition;

FAR Clause 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards (Oct 2018)

FAR Clause 52.204-25 - Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2019)

FAR Clause 52.209-6 Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment (Oct 2015)

FAR Clause 52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (Oct 2014)

FAR Clause 52.219-28 Post Award Small Business Program Representation (Jul 2013)

FAR Clause 52.222-3 Convict Labor (June 2003)

FAR Clause 52.222-19 Child Labor – Cooperation with Authorities and Remedies (Jan 2018)

FAR Clause 52.222-21 Prohibition of Segregated Facilities (Apr 2015)

FAR Clause 52.222-26 Equal Opportunity (Sept 2016)

FAR Clause 52.222-36 Equal Opportunity for Workers with Disabilities (July 2014)

FAR Clause 52.222-50 Combating Trafficking in Persons (Jan 2019)

FAR Clause 52.223-18 Encouraging Contractor Policies to Ban Text Messaging While Driving (AUG 2011)

FAR Clause 52.225-3, Buy American—Free Trade Agreements—Israeli Trade Act (May 2014) Alternate II (May 2014) of 52.225-3

FAR Clause 52.225-13 Restrictions on Certain Foreign Purchases (June 2008)

FAR Clause 52.232-33 Payment by Electronic Funds Transfer–System for Award Management (SAM) (Oct 2018)

SUBMISSION INFORMATION

Quotations must be submitted via email to Contract Specialist, Kathy Elliott, at Elliottk@mail.nih.gov in MS Word or Adobe Portable Document Format (PDF), no later than 5:00 PM EST, on Monday, September 9, 2019. All responses must be received by the specified due date and time in order to be considered. QUOTATIONS RECEIVED AFTER THIS DATE AND TIME WILL NOT BE CONSIDERED. No collect calls will be accepted.

Please refer to solicitation no: 75N91019Q00125-A on all correspondence.

Full text copies of the representations and certifications for other cited provisions and clauses may be obtained on line at the NCI website at http://ncioa.cancer.gov/oa-internet/reference.jsp

OFFERORS: Offers must be submitted on an SF-1449 with a completed 52.212-3 Offeror Representations and Certifications-Commercial Items-with DUNS Number Addendum, signed by an authorized representative of the offeror OR provide a copy of the valid certification registrations of the offeror’s Excluded Parties List System (EPLS) and Online Representations and Certifications Applications (ORCA) through www.sam.gov. Offerors must also complete and submit with Quote, FAR 52.204-24 Section (c) Representation.

mailto:Elliottk@mail.nih.gov mailto:Elliottk@mail.nih.gov http://ncioa.cancer.gov/oa-internet/reference.jsp http://ncioa.cancer.gov/oa-internet/reference.jsp http://www.sam.gov/ http://www.sam.gov/